Altarac David 4
4 · Entasis Therapeutics Holdings Inc. · Filed Jan 19, 2022
Insider Transaction Report
Form 4
Altarac David
Chief Medical Officer
Transactions
- Award
Common Stock
2022-01-18+125,000→ 167,572 total
Footnotes (1)
- [F1]This award vests over four years with twenty-five percent of the award vesting on each anniversary of the date of grant, subject to the reporting person's continued employment with the Company.